In our study, we also found that SAA was highly expressed in lung cancer tissues; therefore, we presume that circulating CRP may easily contact SAA produced by lung cancer cells to form the CRP-SAA complex, and the appearance of CRP-SAA in the serum could be a predictive biomarker for lung cancer progression. The gene discussed is CRP; the disease is lung carcinoma.